Skip to main content Skip to main navigation menu Skip to site footer

High c-reactive protein level as risk factors of complications in upper gastrointestinal bleeding

  • I Ketut Mariadi ,
  • Karismayusa Sudjana ,
  • I Dewa Nyoman Wibawa ,

Abstract

Purpose: Upper gastrointestinal bleeding is the major medical emergency case in the field of gastroenterology. The complications of UGI bleeding are recurrent bleeding and death. Identifying risk factors for the complications is expected to prevent or reduce recurrent bleeding complications and deaths from UGI bleeding. This study aims to know the risk of UGI bleeding complications in patients with a high level of C reactive protein (CRP).

Patients and methods: A prospective observational analytic study was performed, including all UGI bleeding patients (variceal and nonvariceal). CRP level was used to determine the high-risk cohort. High-risk cohort if the CRP level 5 mg/L and above, and low risk if CRP level less than 5 mg/L. The outcome of the study was the incidence of complication, both rebleeding and death during follow up for six weeks. 

Results: Based on the characteristic data of the sample, the high-risk group appears to have a slightly older age, higher leucocyte count, lower hemoglobin levels, and higher serum creatinine than the low-risk group. The incidence rate of complication in the high-risk group was 85.3% while in the low-risk group was 37.5%, and the relative risk (RR) was 2.27 (95% CI: 1.43-3.67). There were significant differences in the incidence of complications between the group, X2: 16; p <0.001. The RR for rebleeding in the high-risk to low-risk cohort was 2.68 (95% CI: 1.31-5.47); this difference is statistically significant (X2:9.3; p=0.02). The RR for death complication was 1.70 (95% CI: 0.63-4.53), and the difference is not statistically significant (X2: 1.2; p=0.28).

Conclusion: In this study, we found the CRP level ≥ 5 mg/L as a significant risk factor for rebleeding complications but not mortality in a patient with UGI bleeding.

References

  1. Hwang JH, Fisher DA, Ben-Menachem T, et al. The role of endoscopy in the management of acute nonvariceal upper GI bleeding. Gastrointest Endosc. 2012;75(6):1132-1138. doi:10.1016/j.gie.2012.02.033
  2. Milenkovic M, Russo CA, Elixhauser A. Hospital Stays for Gastrointestinal Diseases, 2004. HCUP Statistical Brief #12. Agency for Healthcare Research and Quality, Rockville, MD. 2006. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb12.pdf.
  3. Cremers I, Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol. 2014;7(5):206-216. doi:10.1177/1756283X14538688
  4. van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):209-224. doi:10.1016/j.bpg.2007.10.011
  5. Hreinsson JP, Kalaitzakis E, Gudmundsson S, Björnsson ES. Upper gastrointestinal bleeding: Incidence, etiology and outcomes in a population-based setting. Scand J Gastroenterol. 2013;48(4):439-447. doi:10.3109/00365521.2012.763174
  6. Moledina SM, Komba E. Risk factors for mortality among patients admitted with upper gastrointestinal bleeding at a tertiary hospital: A prospective cohort study. BMC Gastroenterol. 2017;17(1):1-11. doi:10.1186/s12876-017-0712-8
  7. Khamaysi I, Gralnek IM. Acute upper gastrointestinal bleeding (UGIB) - Initial evaluation and management. Best Pract Res Clin Gastroenterol. 2013;27(5):633-638. doi:10.1016/j.bpg.2013.09.002
  8. Ramaekers R, Mukarram M, Smith CAM, Thiruganasambandamoorthy V. The Predictive Value of Preendoscopic Risk Scores to Predict Adverse Outcomes in Emergency Department Patients With Upper Gastrointestinal Bleeding: A Systematic Review. Acad Emerg Med. 2016;23(11):1218-1227. doi:10.1111/acem.13101
  9. Kim YD. Management of Acute Variceal Bleeding. Clin Endosc. 2014;47(4):308. doi:10.5946/ce.2014.47.4.308
  10. Nam JH, Jeon TJ, Cho JH, Kim JH. Risk factors of the rebleeding according to the patterns of nonvariceal upper gastrointestinal bleeding. Turkish J Gastroenterol. 2017;28(4):266-271. doi:10.5152/tjg.2017.17066
  11. Robinson M, Syam AF, Abdullah M, A A. Mortality Risk Factors in Acute Upper Gastrointestinal Bleeding. Indones J Gastroenterol Hepatol Dig Endosc. 2012;13(1):37-42. doi:10.24871/131201237-42
  12. Ho KM, Lee KY, Dobb GJ, Webb SAR. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: A prospective cohort study. Intensive Care Med. 2008;34(3):481-487. doi:10.1007/s00134-007-0928-0
  13. Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage : European Society of Gastrointestinal Endoscopy ( ESGE ) Guideline Authors European Society of Gastrointestinal Endoscopy. Endoscopy. 2015;47:1-46.
  14. Baskett PJ. ABC of major trauma. Management of hypovolaemic shock. BMJ. 1990;300(6737):1453-1457. http://www.ncbi.nlm.nih.gov/pubmed/2198971%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1663124.
  15. Barkun A, Bardou, John K M. Clinical Guidelines Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. Am Coll Physicians. 2003;139:843-857.
  16. Maggio D, Barkun AN, Martel M, Elouali S, Gralnek IM, Investigators the R. Predictors of early rebleeding after endoscopic therapy bleeding secondary to high-risk lesions. Can J Gastroenterol. 2013;27(8):454-458.
  17. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38(3):316-321. doi:10.1136/gut.38.3.316
  18. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for uppergastrointestinal haemorrhage. Lancet. 2000;356:1318-1321.
  19. Enns RA, Gagnon YM, Barkun AN, et al. Validation of the Rockall scoring system for outcomes from nonvariceal upper gastrointestinal bleeding in a Canadian setting. World J Gastroenterol. 2006;12(48):7779-7785. doi:10.3748/wjg.v12.i48.7779
  20. Lee HH, Park JM, Lee SW, et al. C-reactive protein as a prognostic indicator for rebleeding in patients with nonvariceal upper gastrointestinal bleeding. Dig Liver Dis. 2015;47(5):378-383. doi:10.1016/j.dld.2015.02.008
  21. Nozoe T, Matsumata T, Sugimachi K. Clinical impact of patients with ruptured esophageal varices with death outcome. Hepatogastroenterology. 2002;49(43):185-187.
  22. Darlington GJ, Wilson DR, Lachman LB. Monocyte-conditioned medium, IL-1 and TNF stimulate the acute phase response in human hepatoma cells in vitro. JCellBiol. 1986;103(September):787-793.
  23. Tomizawa M, Shinozaki F, Hasegawa R, et al. Reduced hemoglobin and increased C-reactive protein are associated with upper gastrointestinal bleeding. World J Gastroenterol. 2014;20(5):1311-1317. doi:10.3748/wjg.v20.i5.1311
  24. Waidmann O, Brunner F, Herrmann E, Zeuzem S, Piiper A, Kronenberger B. Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis. J Hepatol. 2013;58(5):956-961. doi:10.1016/j.jhep.2013.01.005

How to Cite

Mariadi, I. K., Sudjana, K., & Wibawa, I. D. N. (2020). High c-reactive protein level as risk factors of complications in upper gastrointestinal bleeding. Bali Medical Journal, 9(3), 698–701. https://doi.org/10.15562/bmj.v9i3.2015

HTML
10

Total
16

Share

Search Panel

I Ketut Mariadi
Google Scholar
Pubmed
BMJ Journal


Karismayusa Sudjana
Google Scholar
Pubmed
BMJ Journal


I Dewa Nyoman Wibawa
Google Scholar
Pubmed
BMJ Journal